Launching to the dental community this May, Dentex is a UK partnership group for the dental profession. Working to a unique co-ownership model, which encourages clinical excellence and growth in profitability, the organisation provides the support that independent dental practitioners need to achieve their full potential, without encroaching on their autonomy.
Established in 2014, the organisation already works with a number of strategically selected partner dentists including Mark Hughes, Stuart Bowen-Davies, Stan Dubowitz, Elaine Halley, Rahul and BhavnaDoshi, Pieter Claassen, Stephen Tarr, and Tidu Mankoo.
Founded by Mark Cockburn, a Chartered Accountant with more than 30 years’ experience, and William Bowen-Davies, an entrepreneur with a successful history in business management and extensive experience in the dental industry, Dentex combines clinical and financial excellence.
Headed up by CEO Barry Lanesman, a qualified Dentist with a 26-year career history and an MBA from the University of Cape Town, Dentex is managed by dentists and others with professional links to the occupation. Coupled with Pat Langley’s (Group Clinical Director at Oasis for 7 years) outstanding clinical support, guidance and leadership, and Christopher Barrow’s (Legal Director, with 20 years’ experience at high profile international law firms) unerring legal expertise, the Dentex team have extremely strong foundations.
Lanesman comments: ‘The Dentex mission is to foster clinical excellence and freedom in dentistry. It is important that we collaborate with our partnering dentists, enabling them a way to enhance and share their skills. This means that with our support they can grow more than they could have on their own, whilst retaining clinical control of their business. These goals and values are shared by our funders at Universal Partners.It’s a unique approach, but one that we feel really meets the needs of dentists today – we believe what we are building will revolutionise dentistry in the UK’
Andrew Birrell, Executive Director at Universal Partners comments: ‘Universal Partners are delighted to fund Dentex, to support the delivery of the unique clinical partnership model. As a long-term capital provider, we are committed to partnership and we believe that Dentex will make a lasting, positive impact by allowing clinicians to set high clinical standards, whilst benefiting from a strong capital provider.
Dentex works with two partner types:
Dentex co-founder Mark Cockburn comments: ‘Dentex supports dentists in running their practices by providing mentoring, guidance, technical, financial, regulatory, legal and clinical help as needed. Partners retain full clinical control of their businesses and gain the reassurance of a safety net.’
‘At Dentex we believe in a culture of integrity, respect, and the highest ethical standards,’ he adds. ‘We work with passion and determination in everything that we do, while continuously searching to innovate, improve and evolve. These are the qualities which we are looking for in any future practice or regional partners.’
Regional Partner, Mark Hughes of SD Dentco, comments: ‘Patient-centred dentistry has always been a passion of mine. Having developed my own group of practices, as well as worked with and sold to large dental corporates, Dentex was the only option that allowed me to continue to provide the highest quality care and personal attention that I am used to. Being able to retain my own philosophy and practice identity was key in my decision to join.’
‘In my opinion, they are the only investment vehicle that offers true partnership in growing our businesses together. Any concerns I had were quickly abated after meeting the exceptional support team Dentex has pulled together. The wealth of experience and support they offer is second to none in the UK.’
‘The ability to release equity and still remain in control of my business was key and with the support of the Dentex team I can achieve growth much quicker than I could have on my own.’
Clinically proven to reduce gum problems with unique ActivREPAIR™ technology
Today at the BDA Conference, Oral-B has launched the NEW Oral-B Gum & Enamel Repair Toothpaste.
Gum problems, a leading cause of tooth loss, can often be prevented through proper at-home oral care and regular visits to a dental professional. Today, more than 50% of the world’s adult population suffers from gum problems and in most/many cases patients ignore or even do not notice the symptoms of gum problems until it is too late, something that must be incredibly frustrating for a dental professional.
Dr Phil Ower, immediate past president of the British Society of Periodontology, commented: “It is our duty as dental professionals to act in the prevention, early diagnosis, and effective treatment of gum problems in order to combat the potentially serious effect of these issues."
Proper brushing, coupled with specialized toothpaste, not only can prevent gum problems, but also improve gum health.
Proper mechanical plaque control is the cornerstone to reduce gingivitis. However, there is clinical evidence that specialized toothpaste can provide additional gum health benefits. More specifically, over 31 studies show that Stabilized Stannous Fluoride adds value to tooth-brushing through reducing gum inflammation and bleeding.
“Oral-B has a long history of supporting dental professionals. Our goal is to always provide superior oral care products that continue the care that starts in your chair, helping your patients achieve stronger teeth and healthier gums”, stated Jane Kidson, Oral-B Professional Oral Health Country Manager.
Oral-B first introduced Stannous Fluoride in the 1950’s to prevent carries. Since then, Oral-B invested over a decade of research to evolve the Stannous technology to also help patients significantly improve gum health and prevent enamel erosion.
Today, Oral-B is introducing the NEW Oral-B Gum & Enamel Repair Toothpaste to help patients address the increasing prevalence of gum or enamel issues. Featuring unique ActivRepairTM technology (with 2 sources of Stannous: Stannous Fluoride and Stannous Chloride), it is the best clinically-proven toothpaste from Oral-B to help restore gum health and prevent enamel erosion.
Benefits of Oral-B Gum & Enamel Repair Toothpaste
NEW Oral-B Gum & Enamel Repair is the best clinically-proven toothpaste from Oral-B to help reduce gum problems and prevent enamel erosion.
Reduces gum problems[i]
Helps prevent enamel erosioni
Benefits of Brushing with Oral-B
The use of a specialized toothpaste such as Oral-B Gum & Enamel Repair Toothpaste, in combination with Oral-B’s iconic round brush head that cleans better than a manual toothbrush, supports your patients by helping them to brush at their best.
The unique features of Oral-B’s round brush head embrace and adapt to each tooth to deliver superior results on plaque and gum vs. a regular manual toothbrush. The Oral-B round head and technology has been validated consistently by external and internal clinical research to deliver:
· Superior plaque removal: Removes 2x more plaque vs. a regular manual toothbrush[iv]
· Healthier gums: 36% reduction in gum bleeding sites vs. Sonicare[v] and 2x as effective at reducing gingivitis vs. a regular manual brushes[vi]
· Preferred by patients: 66% preferred Oral-B vs. 31% for a sonic brush[vii]
An independent review of published research by the Cochrane Collaboration[viii] also confirmed the superiority and effectiveness of oscillating-rotating power technology over manual brushes, whilst recognizing its safety.
Help your patients brush their very best and achieve better gum and enamel health with Oral-B Gum & Enamel Repair Toothpaste and an Oral-B electric rechargeable toothbrush.
Oral-B Partners with HPV Action to Improve the Lives of People in the UK
Oral-B strives to help consumers improve their oral health, an important part of overall health and wellness. Research shows that gum issues and particularly gingivitis affect 1 out of 2 adults worldwidei. Some studies also suggest poor gum health is associated with heart disease, diabetes and even premature birth[ix],[x]. As part of our effort to improve the overall health and wellbeing of consumers in the UK, Oral-B has partnered with HPV Action (HPVA), a collaborative partnership of 46 patient and professional organisations that are working to reduce the health burden of HPV, which is estimated to be the cause of 5% of all cancer cases[xi]. Oral-B will donate £5 for each completed Oral-B Gum & Enamel Repair Toothpaste dental patient evaluation programme. All forms received by the end of October 2017 will qualify. Together with HPV Action we believe that we can make an important difference in the lives of consumers in the UK.
About Oral-B
Oral-B® is the worldwide leader in the over $5 billion brushing market. Part of the Procter & Gamble Company, the brand includes manual and electric toothbrushes for children and adults, oral irrigators and interdental products, such as dental floss. Oral-B® manual toothbrushes are used by more dentists than any other brand in the U.S. and many international markets.
References
[i] In a laboratory study on weakened enamel
[ii] Gerlach R and Amini P. Comp Cont Dent Educ 2012; 33 (2), 138-142
[iii] Against food acids vs. ordinary toothpastes
[iv] Compend Cont Educ Dent 2014; 25(9):702-706
[v] Oral-B Pro CrossAction vs Sonicare DiamondClean”, J Clin Dent 2015; 26:80-85
[vi] J Dent Res (AADR/IADR) 2014;93 (Specs Iss A): Abstract 1366
[vii] Among 64 people participating in a clinical trial; P&G Data on file
[viii] http://www.cochrane.org/CD002281/ORAL_poweredelectric-toothbrushes-compared-to-manual-toothbrushes-for-maintaining-oral-health
[ix] Chapple IL, Genco R. Working group 2 of the joint EFP/AAP workshop. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontal 2013; 84: S106-112 [PMID 23631572 DOI: 10.1902/jop.2013.1340011].
[x] Ide M, Papapanou PN. Epidemiology of association between maternal periodontal disease and adverse pregnancy outcomes – Systemic review. J Periodontal 2013; 84(suppl 4):S181-S194.
[xi] de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncology 2012; 13(6):607-615.
BioHorizons is delighted to announce a 20% discount off the registration fee for all courses taking place in June 2017.
All you need to do is book before 26 May and input the discount code ‘SUMMERSALE’ at checkout.
The courses running this June are:
The British Society of Dental Hygiene and Therapy (BSDHT) and the British Association of Dental Therapists (BADT) have united to apply for prescribing exemptions that would broaden dental hygienists’ and dental therapists’ scope of practice for the benefit of their patients.
Driven by respective immediate past presidents – Michaela O’Neill and Fiona Sandom – we were recently given the green light by the Department of Health to move into the next stage of the campaign.
To do so, we need your help.
Have you had to send patients away with incomplete or no treatment because you couldn’t get a prescription when you needed it? How did this affect your ability to deliver patient care? What would it mean to be able to provide certain prescription only medicines, without requiring a prescription from the dentist?
The more examples of cases we can collect for the cause, the bigger a voice we will have. Please email your experiences and the impact these had on you, your patients and your practice to This email address is being protected from spambots. You need JavaScript enabled to view it..
By working together, we can drive change.
For more information about this intuitive or about the BSDHT, please visit www.bsdht.org.uk, email This email address is being protected from spambots. You need JavaScript enabled to view it. or call 01788 575050